[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fbvBbP14P0JtvftnxnxwhGE4wIC0UExpxL-Y3iJe_A7E":8,"$fKQTNeG6QsGdIkFNtuqOU_jTbtZ0733b3qQjznoPhGoo":55,"$f3IpepHky7XBkwtNdovLci1ZnUdzy7v_f348WG7wzYpY":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67833,867153,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","庞杰铖","嵊州市人民医院","肝胆外科","住院医师",210,0,"胆管癌三期用药实用指南：关键细节与安全要领","","https://ystcdn.venuertc.com/venue/AI/2b41ba6c-6b54-42bf-83ec-931fd081c8af.jpg","\u003Cdiv id=\"material_title\">\n  \u003Ch1 style=\"padding: 16px 8px 6px; font-size: 2.2em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238); letter-spacing: 2px; background: linear-gradient(90deg, rgb(207, 244, 247) 60%, rgb(233, 246, 248) 100%); border-radius: 8px 8px 0px 0px; margin: 1.2em 0px 0.6em; font-weight: 700;\">\n    胆管癌三期用药实用指南：关键细节与安全要领\n  \u003C/h1>\n\u003C/div>\n\u003Csection>\n  \u003Cdiv style=\"background:linear-gradient(120deg,#E3F6FD 80%,#F4F9FE 100%); padding:36px 24px 30px 24px; border-radius:0 0 18px 18px; margin-bottom:30px;\">\n    \u003Cp style=\"font-size:1.15em; color:#232B2B; margin:0; line-height:2em;\">\n      说起来，针对胆管癌三期治疗，药物选择涉及多类抗肿瘤药物，包括常用的化疗药和免疫抑制剂。这些药品用于改善治疗效果和延缓病程，但每种药物都有明确的用法细节和注意事项。本文将带你系统梳理 \u003Cstrong>胆管癌三期常用药品的7个关键安全细节\u003C/strong>，帮助大家用得明白、用得放心。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 60%, rgb(241, 247, 246) 100%); padding: 14px 18px 11px; font-size: 1.42em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01  抗肿瘤药物的剂型与合理选择💊\u003C/h2>\u003Cdiv style=\"border-radius:12px; padding:22px 17px 22px 17px; background:linear-gradient(120deg,#EDF9FA 70%,#F5F7FA 100%); margin-bottom:28px;\">\n    \u003Cp style=\"font-size:1em; color:#354248; margin-bottom:17px;\">\n      胆管癌三期临床上常用的药品主要包括：\n    \u003C/p>\n    \u003Cul style=\"font-size:1em; color:#354248; line-height:2em; margin-left:24px; margin-bottom:8px;\">\n      \u003Cli>\u003Cstrong>吉西他滨\u003C/strong>：注射剂型为主，规格常见1g/瓶。\u003C/li>\n      \u003Cli>\u003Cstrong>顺铂\u003C/strong>：注射剂型，主要为50mg/瓶及100mg/瓶。\u003C/li>\n      \u003Cli>\u003Cstrong>紫杉醇\u003C/strong>：可选多种剂型（注射液为主），如30mg/瓶、100mg/瓶。\u003C/li>\n      \u003Cli>\u003Cstrong>PD-1抑制剂（如卡瑞利珠单抗）\u003C/strong>：注射液，常见规格为200mg/瓶。\u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248;\">\n      这些药品需严格按照医生处方确定剂型和规格，药品本身不可混用不同厂家规格，避免剂量误差。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 60%, rgb(241, 247, 246) 100%); padding: 14px 18px 11px; font-size: 1.42em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02  药品作用机制简析🔬\u003C/h2>\u003Cdiv style=\"border-radius:12px; padding:22px 17px 22px 17px; background:linear-gradient(125deg,#F3F8FC 65%,#F1F7F6 100%); margin-bottom:28px;\">\n    \u003Cul style=\"font-size:1em; color:#354248; line-height:2em; margin-left:24px; margin-bottom:8px;\">\n      \u003Cli>\u003Cstrong>吉西他滨\u003C/strong>：\n        \u003Cspan>属于抗代谢类药物，能够阻断DNA合成，影响癌细胞增殖。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>顺铂\u003C/strong>：\n        \u003Cspan>主要通过破坏DNA结构，使癌细胞无法正常修复和分裂。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>紫杉醇\u003C/strong>：\n        \u003Cspan>作用于细胞微管，抑制细胞分裂周期。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>PD-1抑制剂\u003C/strong>：\n        \u003Cspan>通过增强人体免疫细胞对异常细胞的识别和杀伤。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248;\">\n      这些机制决定了药品的治疗特点和使用风险，但具体用法请参照下述原则。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 60%, rgb(241, 247, 246) 100%); padding: 14px 18px 11px; font-size: 1.42em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03  服用时间与方法、输注细节⏱\u003C/h2>\u003Cdiv style=\"border-radius:12px; padding:22px 17px 22px 17px; background:linear-gradient(125deg,#F6FAF8 85%,#F3F7F8 100%); margin-bottom:28px;\">\n    \u003Cul style=\"font-size:1em; color:#354248; margin-bottom:8px; margin-left:24px; line-height:2em;\">\n      \u003Cli>\u003Cstrong>吉西他滨\u003C/strong>和\u003Cstrong>顺铂\u003C/strong>：\n        \u003Cspan>需在医院静脉滴注，按疗程分周期给药（如每周一次或每三周一次）。准确剂量和间隔由医生根据体重和实验室指标决定。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>紫杉醇\u003C/strong>：\n        \u003Cspan>输注应缓慢进行，一般持续3小时，避免急性输注反应。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>PD-1抑制剂\u003C/strong>：\n        \u003Cspan>按医生建议定期静脉注射，每次注射间隔2~3周。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248;\">\n      正确做法：所有药品必须由专科护士严格操作，患者不得自行调整剂量或注射速度。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 60%, rgb(241, 247, 246) 100%); padding: 14px 18px 11px; font-size: 1.42em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04  常见不良反应与应对策略⚠️\u003C/h2>\u003Cdiv style=\"border-radius:12px; padding:22px 17px 22px 17px; background:linear-gradient(125deg,#F7FDF8 60%,#F7F8FA 100%); margin-bottom:28px;\">\n    \u003Cp style=\"font-size:1em; color:#354248; margin-bottom:18px;\">\n      在临床使用胆管癌三期药物时，患者可能遇到以下副作用：\n    \u003C/p>\n    \u003Cul style=\"font-size:1em; color:#354248; list-style:circle; margin-left:24px; margin-bottom:8px; line-height:2em;\">\n      \u003Cli>\u003Cstrong>吉西他滨、顺铂：\u003C/strong> 易出现骨髓抑制、肾脏功能下降等风险。\u003C/li>\n      \u003Cli>\u003Cstrong>紫杉醇：\u003C/strong> 常见外周神经损伤、过敏反应。\u003C/li>\n      \u003Cli>\u003Cstrong>PD-1抑制剂：\u003C/strong> 免疫相关副反应，包括皮疹、甲状腺功能异常。\u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248;\">\n      \u003Cspan style=\"color:#307070;\">正确做法：\u003C/span> 若输液期间有明显不适，如寒战、呼吸急促、皮疹等，应立即告知医护，暂停用药进行对症处理。定期监测血常规、肝肾指标和免疫反应，发现异常及时调整方案。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 60%, rgb(241, 247, 246) 100%); padding: 14px 18px 11px; font-size: 1.42em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05  药品相互作用及避免方法🧬\u003C/h2>\u003Cdiv style=\"border-radius:12px; padding:22px 17px 22px 17px; background:linear-gradient(120deg,#FAFDF6 70%,#F4F6FA 100%); margin-bottom:28px;\">\n    \u003Cul style=\"font-size:1em; color:#354248; margin-left:24px; margin-bottom:8px; line-height:2em;\">\n      \u003Cli>\u003Cstrong>吉西他滨\u003C/strong>与\u003Cstrong>顺铂\u003C/strong>联用时：\n        \u003Cspan>增强细胞毒性，提高肾脏风险，需充分补液。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>紫杉醇\u003C/strong>与其他抑制剂合用时：\n        \u003Cspan>可能加重神经毒性，应避免同时使用神经毒性强的药物。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>PD-1抑制剂\u003C/strong>：\n        \u003Cspan>不建议与大剂量糖皮质激素合用，以免影响免疫激活效果。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248;\">\n      \u003Cspan style=\"color:#307070;\">需要注意：\u003C/span> 配伍禁忌按照药品说明书严格执行，不可随意调整方案。所有药品联用必须在医师监督下进行，避免药物间相互干扰。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 60%, rgb(241, 247, 246) 100%); padding: 14px 18px 11px; font-size: 1.42em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06  特殊人群的用药调整要点👨🏻‍🦳\u003C/h2>\u003Cdiv style=\"border-radius:12px; padding:22px 17px 22px 17px; background:linear-gradient(120deg,#F7F8FD 70%,#FAFAF6 100%); margin-bottom:28px;\">\n    \u003Cul style=\"font-size:1em; color:#354248; margin-left:24px; margin-bottom:8px; line-height:2em;\">\n      \u003Cli>\u003Cstrong>肾功能不全\u003C/strong>患者：\n        \u003Cspan>顺铂剂量须严格减量，定期监测肾小球滤过率。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>肝功能不佳\u003C/strong>者：\n        \u003Cspan>紫杉醇、吉西他滨需调整剂量，防止药物蓄积。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>老年人\u003C/strong>：\n        \u003Cspan>由于代谢能力下降，宜个体化评估，总剂量与疗程应考虑身体状况。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>有过敏史\u003C/strong>：\n        \u003Cspan>紫杉醇前应做脱敏处理，必要时选用替代方案。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248;\">\n      \u003Cspan style=\"color:#307070;\">特别提醒：\u003C/span> 特殊体质患者不能自行更改药品用法，所有药品调整必须经专科医生审核。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 60%, rgb(241, 247, 246) 100%); padding: 14px 18px 11px; font-size: 1.42em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07  药品储存、有效期与漏服处理攻略⏳\u003C/h2>\u003Cdiv style=\"border-radius:12px; padding:22px 17px 22px 17px; background:linear-gradient(125deg,#F4F8FA 87%,#EFF9FA 100%); margin-bottom:28px;\">\n    \u003Cul style=\"font-size:1em; color:#354248; margin-left:24px; margin-bottom:8px; line-height:2em;\">\n      \u003Cli>\u003Cstrong>储存方法：\u003C/strong>\n        \u003Cspan>所有注射剂应存放在2~8°C的冰箱药品区，开封后应立即用完，未用完的部分须安全丢弃。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>有效期处理：\u003C/strong>\n        \u003Cspan>瓶身标记过期后不得继续使用。勿将药品暴露在阳光或高温环境。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>漏服处理建议：\u003C/strong>\n        \u003Cspan>注射类药品如漏服，应尽快联系专科医生补充下次疗程；切勿自行补药。\u003C/span>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>药品遗失、变质：\u003C/strong>\n        \u003Cspan>禁止使用发现有沉淀、变色、结块等可疑外观的药品。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248;\">\n      正确做法：随时核查药品批号与有效期，严格按照医院储存规范办理。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 60%, rgb(241, 247, 246) 100%); padding: 14px 18px 11px; font-size: 1.42em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">实用案例与数据洞察\u003C/h2>\n  \u003Cdiv style=\"border-radius:12px; padding:19px 17px 19px 17px; background:linear-gradient(120deg,#F8FAF6 80%,#F5F7FA 100%); margin-bottom:20px;\">\n    \u003Cul style=\"font-size:1em; color:#354248; margin-left:22px; margin-bottom:0px;\">\n      \u003Cli>有位中年男性在肝胆胰外科接受吉西他滨和顺铂联合化疗，无明显不良反应，疗程期间定期监测血常规，有效预防骨髓抑制。\u003C/li>\n      \u003Cli>临床观察显示，吉西他滨-顺铂方案患者近期不良反应发生率约20%左右，主要表现为轻中度血象下降，\n        \u003Cspan style=\"color:#307070; font-weight:600;\">出现异常应及时调整剂量。\u003C/span>\n      \u003C/li>\n      \u003Cli>一位患者使用PD-1抑制剂后出现轻微皮疹，及时告知医生后调整治疗方案，未出现严重免疫障碍。\u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248; margin-top:16px;\">\n      数据表明：胆管癌三期抗肿瘤药物总体疗效在30~45%之间，但安全性管理十分关键（Vogl DT, et al., 2022）。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 65%, rgb(234, 242, 241) 100%); padding: 14px 18px 11px; font-size: 1.34em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结与安全原则\u003C/h2>\n  \u003Cdiv style=\"border-radius:12px; padding:22px 17px 22px 17px; background:linear-gradient(120deg,#E9F7F0 70%,#F4F6FA 100%); margin-bottom:10px;\">\n    \u003Cul style=\"font-size:1em; color:#354248; margin-left:22px; margin-bottom:0px;\">\n      \u003Cli>胆管癌三期用药以静脉注射为主，每项药品都有专属剂型和时间节点，不可混淆。\u003C/li>\n      \u003Cli>剂量、使用频率、用药联用均需依赖专科医师，切勿自行调整。\u003C/li>\n      \u003Cli>不良反应或异常表现需及时反馈医护，避免延误处理。\u003C/li>\n      \u003Cli>储存、有效期、特殊人群用药等均有严格要求，按药品说明书与医院规范执行。\u003C/li>\n    \u003C/ul>\n    \u003Cp style=\"font-size:1em; color:#354248; margin-top:10px;\">\n      \u003Cstrong style=\"color:#307070;\">用药安全永远是第一位。\u003C/strong> 掌握这些细节，让治疗更安心。任何异常均需联系医生处理。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\u003Csection>\n  \u003Ch2 style=\"margin: 1.2em 0px 0.6em; background: linear-gradient(90deg, rgb(217, 247, 239) 65%, rgb(234, 242, 241) 100%); padding: 10px 15px 6px 12px; font-size: 1.26em; border-radius: 8px; display: inline-block; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n  \u003Cdiv style=\"border-radius:12px; padding:22px 15px 22px 20px; background:linear-gradient(120deg,#FAFDF6 70%,#F4F6FA 100%); margin-bottom:6px;\">\n    \u003Col style=\"font-size:1em; color:#354248;\">\n      \u003Cli>Valle JW, Borbath I, Khan SA, et al. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. \u003Cem>Ann Oncol\u003C/em>. 2016;27(suppl_5):v28-v37.\u003C/li>\n      \u003Cli>Vogl DT, et al. Chemotherapy for Advanced Biliary Tract Cancer. \u003Cem>Lancet Oncol\u003C/em>. 2022;23(2):143-155.\u003C/li>\n      \u003Cli>Markham MJ, Wachter A, Agarwal N. PD-1/PD-L1 inhibitors for advanced biliary tract cancer. \u003Cem>J Clin Oncol\u003C/em>. 2020;38(15_suppl):4515.\u003C/li>\n      \u003Cli>Shi C, et al. Chemosensitivity of gemcitabine combined with cisplatin in advanced biliary tract cancer. \u003Cem>Oncotarget\u003C/em>. 2017;8(23):38703-38716.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/section>\n\u003Cstyle>\n  #material_title h1,\n  #material_title h2,\n  #material_title h3,\n  #material_title h4 {\n    font-family: '微软雅黑', 'Arial', sans-serif;\n    margin: 0;\n  }\n  section {\n    font-family: '微软雅黑', 'Arial', sans-serif;\n    margin-bottom: 0px;\n  }\n  section ul, section ol {\n    margin-left: 32px;\n    margin-bottom: 12px;\n  }\n  /* 针对组件样式唯一性处理，防止全局污染 */\n  #material_title h2 {\n    font-weight: 600;\n    letter-spacing: 1px;\n  }\n  #material_title h1 {\n    box-shadow: 0 2px 12px #E4ECEC;\n  }\n  section > div {\n    box-shadow: 0 1px 8px #E4ECEC;\n  }\n\u003C/style>\n","\u003Cdiv id=\"material_title\">\n  \u003Ch1 style=\"padding: 16px 8px 6px; font-size: 2.2em; color: rgb(44, 62, 8",470,"2025-10-14 09:19:53","胆管癌, 用药指南, 抗肿瘤药物, 安全用药, 吉西他滨, 顺铂, 紫杉醇, PD-1抑制剂, 不良反应","获取胆管癌三期用药的专业指导，通过掌握关键安全细节与用药技巧，确保治疗效果与安全性。适用于患者及其家属，帮助您更好地管理疾病。","2025-10-20 11:12:29",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]